| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |